In [50], a metasignature was identified in eight separate microarray analyses spanning seven types of cancer including lung adenocarcinoma, and these included many genes associated with cell proliferation, and CDKN3 is among them. The gene discussed is CDKN3; the disease is lung adenocarcinoma.